Latest Pharmacogenetics Stories
Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.
LONDON, June 9, 2011 /PRNewswire/ -- London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, is pleased to announce that its third annual pharmacogenetic conference will feature top-level presentations from players in all parts of the healthcare chain.
CINCINNATI, May 12, 2011 /PRNewswire/ -- AssureRx Health, Inc., today announced two presentations on the clinical practice of utilizing its pharmacogenetic test, GeneSightRxÂ®, at the 164th Annual Meeting of the American Psychiatric Association (APA) in Honolulu, May 14-18, 2011.
FRANKLIN LAKES, N.J. and CINCINNATI, May 11, 2011 /PRNewswire/ -- Medco Research Institute LLC, a wholly owned subsidiary of Medco Health Solutions Inc. (NYSE: MHS), and AssureRx Health Inc.
The drug, called carbamazepine, is commonly used to treat patients with epilepsy and other diseases such as depression and trigeminal neuralgia.
- Emitting flashes of light; glittering.